Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003826

Options or other derivatives

  • Chief Financial Officer returned 7,041 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Sassi Nir · Chief Financial Officer

Table II: Derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-10 Returned to the company : show line 1 in the form Stock Option (right to buy) −1,250 $0.07 $89 0 D
2025-04-10 Returned to the company : show line 2 in the form Stock Option (right to buy) −1,125 $0.07 $80 0 D
2025-04-10 Returned to the company : show line 3 in the form Stock Option (right to buy) −2,500 $0.07 $178 0 D
2025-04-10 Returned to the company : show line 4 in the form Stock Option (right to buy) −500 $0.07 $36 0 D
2025-04-10 Returned to the company : show line 5 in the form Stock Option (right to buy) −500 $0.07 $36 0 D
2025-04-10 Returned to the company : show line 6 in the form Stock Option (right to buy) −41 $0.07 $3 0 D
2025-04-10 Returned to the company : show line 7 in the form Stock Option (right to buy) −1,125 $0.07 $80 0 D
Loading xslF345X05/ownership.xml…